350 related articles for article (PubMed ID: 24030360)
1. Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.
Janefjord E; Mååg JL; Harvey BS; Smid SD
Cell Mol Neurobiol; 2014 Jan; 34(1):31-42. PubMed ID: 24030360
[TBL] [Abstract][Full Text] [Related]
2. Contrasting protective effects of cannabinoids against oxidative stress and amyloid-β evoked neurotoxicity in vitro.
Harvey BS; Ohlsson KS; Mååg JL; Musgrave IF; Smid SD
Neurotoxicology; 2012 Jan; 33(1):138-46. PubMed ID: 22233683
[TBL] [Abstract][Full Text] [Related]
3. Piper sarmentosum Roxb. confers neuroprotection on beta-amyloid (Aβ)-induced microglia-mediated neuroinflammation and attenuates tau hyperphosphorylation in SH-SY5Y cells.
Yeo ETY; Wong KWL; See ML; Wong KY; Gan SY; Chan EWL
J Ethnopharmacol; 2018 May; 217():187-194. PubMed ID: 29462698
[TBL] [Abstract][Full Text] [Related]
4. N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor.
McHugh D; Hu SS; Rimmerman N; Juknat A; Vogel Z; Walker JM; Bradshaw HB
BMC Neurosci; 2010 Mar; 11():44. PubMed ID: 20346144
[TBL] [Abstract][Full Text] [Related]
5. Effects of a Standardized Phenolic-Enriched Maple Syrup Extract on β-Amyloid Aggregation, Neuroinflammation in Microglial and Neuronal Cells, and β-Amyloid Induced Neurotoxicity in Caenorhabditis elegans.
Ma H; DaSilva NA; Liu W; Nahar PP; Wei Z; Liu Y; Pham PT; Crews R; Vattem DA; Slitt AL; Shaikh ZA; Seeram NP
Neurochem Res; 2016 Nov; 41(11):2836-2847. PubMed ID: 27418278
[TBL] [Abstract][Full Text] [Related]
6. 2-Arachidonoylglycerol elicits neuroprotective effects on excitotoxically lesioned dentate gyrus granule cells via abnormal-cannabidiol-sensitive receptors on microglial cells.
Kreutz S; Koch M; Böttger C; Ghadban C; Korf HW; Dehghani F
Glia; 2009 Feb; 57(3):286-94. PubMed ID: 18837048
[TBL] [Abstract][Full Text] [Related]
7. Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures.
Cardinal von Widdern J; Hohmann T; Dehghani F
Molecules; 2020 Jan; 25(3):. PubMed ID: 31979350
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.
Kozela E; Pietr M; Juknat A; Rimmerman N; Levy R; Vogel Z
J Biol Chem; 2010 Jan; 285(3):1616-26. PubMed ID: 19910459
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease.
Martín-Moreno AM; Reigada D; Ramírez BG; Mechoulam R; Innamorato N; Cuadrado A; de Ceballos ML
Mol Pharmacol; 2011 Jun; 79(6):964-73. PubMed ID: 21350020
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation.
Ramírez BG; Blázquez C; Gómez del Pulgar T; Guzmán M; de Ceballos ML
J Neurosci; 2005 Feb; 25(8):1904-13. PubMed ID: 15728830
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of glyceryl nonivamide against microglia-like cells and 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
Lin YC; Uang HW; Lin RJ; Chen IJ; Lo YC
J Pharmacol Exp Ther; 2007 Dec; 323(3):877-87. PubMed ID: 17855475
[TBL] [Abstract][Full Text] [Related]
12. Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoid-type CB2 receptor.
Klegeris A; Bissonnette CJ; McGeer PL
Br J Pharmacol; 2003 Jun; 139(4):775-86. PubMed ID: 12813001
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures.
Kreutz S; Koch M; Ghadban C; Korf HW; Dehghani F
Exp Neurol; 2007 Jan; 203(1):246-57. PubMed ID: 17010339
[TBL] [Abstract][Full Text] [Related]
14. Novel cannabis flavonoid, cannflavin A displays both a hormetic and neuroprotective profile against amyloid β-mediated neurotoxicity in PC12 cells: Comparison with geranylated flavonoids, mimulone and diplacone.
Eggers C; Fujitani M; Kato R; Smid S
Biochem Pharmacol; 2019 Nov; 169():113609. PubMed ID: 31437460
[TBL] [Abstract][Full Text] [Related]
15. Cannabidiol regulates CB1-pSTAT3 signaling for neurite outgrowth, prolongs lifespan, and improves health span in Caenorhabditis elegans of Aβ pathology models.
Wang Z; Zheng P; Xie Y; Chen X; Solowij N; Green K; Chew YL; Huang XF
FASEB J; 2021 May; 35(5):e21537. PubMed ID: 33817834
[TBL] [Abstract][Full Text] [Related]
16. The structurally diverse phytocannabinoids cannabichromene, cannabigerol and cannabinol significantly inhibit amyloid β-evoked neurotoxicity and changes in cell morphology in PC12 cells.
Marsh DT; Sugiyama A; Imai Y; Kato R; Smid SD
Basic Clin Pharmacol Toxicol; 2024 Mar; 134(3):293-309. PubMed ID: 37697481
[TBL] [Abstract][Full Text] [Related]
17. Fucosterol exerts protection against amyloid β-induced neurotoxicity, reduces intracellular levels of amyloid β and enhances the mRNA expression of neuroglobin in amyloid β-induced SH-SY5Y cells.
Gan SY; Wong LZ; Wong JW; Tan EL
Int J Biol Macromol; 2019 Jan; 121():207-213. PubMed ID: 30300695
[TBL] [Abstract][Full Text] [Related]
18.
Kim HL; Min DE; Lee SK; Choi BK; Lee DR
J Med Food; 2023 May; 26(5):328-341. PubMed ID: 37092995
[TBL] [Abstract][Full Text] [Related]
19. Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells.
Juknat A; Pietr M; Kozela E; Rimmerman N; Levy R; Gao F; Coppola G; Geschwind D; Vogel Z
PLoS One; 2013; 8(4):e61462. PubMed ID: 23637839
[TBL] [Abstract][Full Text] [Related]
20. α-Iso-cubebenol inhibits inflammation-mediated neurotoxicity and amyloid beta 1-42 fibril-induced microglial activation.
Park SY; Park TG; Lee SJ; Bae YS; Ko MJ; Choi YW
J Pharm Pharmacol; 2014 Jan; 66(1):93-105. PubMed ID: 24138316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
